Philippe De Du Poet

Title: Philippe De Du Poet: Innovator in Anti-Thrombin Polypeptides

Introduction

Philippe De Du Poet is a notable inventor based in Brussels, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-thrombin polypeptides. His work has implications for treating various thrombotic conditions, showcasing the intersection of biology and medicine.

Latest Patents

Philippe De Du Poet holds a patent for "Anti-thrombin polypeptides and pharmaceutical compositions thereof." This invention relates to anti-thrombin polypeptides isolated from the leech Hirudinaria manillensis. The polypeptides can be modified through amino acid extensions and post-translational modifications. They can be isolated from the leech's tissue or secretions, or synthesized using recombinant DNA methods. The patent also provides DNA sequences, expression vectors, and host cell lines for the recombinant preparation of these polypeptides. The applications of this invention are particularly relevant in treating venous thrombosis, vascular shunt occlusion, and thrombin-induced disseminated intravascular coagulation. Philippe has 1 patent to his name.

Career Highlights

Philippe De Du Poet is associated with Farmitalia Carlo Erba S.r.l., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to advancing medical treatments through scientific research and development.

Collaborations

Philippe has collaborated with notable colleagues such as Paolo Sarmientos and Giampaolo Nitti. Their combined expertise contributes to the innovative environment at Farmitalia Carlo Erba S.r.l.

Conclusion

Philippe De Du Poet's contributions to the field of anti-thrombin polypeptides highlight his role as an important inventor in the pharmaceutical industry. His work not only advances scientific knowledge but also has the potential to improve patient outcomes in thrombotic conditions.